Engimmune Therapeutics
Engimmune Therapeutics - Engineering the next-generation of soluble T cell receptor (TCR) therapies in oncology and immune-mediated disease.
$16M Seed ·
Source: startupintros.com
Funding history ↓Signals
Website registeredJul 10, 2021 (5 years old)
Funding rounds
- Seed · $16MSource: startupintros.com
- Website created
Companies like Engimmune Therapeutics
MMirador Therapeutics$250M Series B+ · Jan 2026
TTinkeso TherapeuticsBBionyra$165M Series A · Jun 2026
KKhartis Therapeutics$95M Series B+ · Aug 2026
HHI-Bio$95M Series B+ · Jan 2024
OOuro Medicines$120M Series A · Jan 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/engimmune-therapeutics (get a free API key).